Smith & Nephew plc (SNN) Bundle
Who Invests in Smith & Nephew plc (SNN) and Why?
Investor Profile Analysis for Medical Technology Company
Institutional investors hold 72.5% of total outstanding shares as of Q4 2023.
| Investor Category | Percentage Ownership |
|---|---|
| Institutional Investors | 72.5% |
| Retail Investors | 27.5% |
Top Institutional Investors
| Investor Name | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group | 45,678,921 | 8.3% |
| BlackRock Inc. | 39,456,123 | 7.1% |
Investment Motivations
- Dividend yield of 3.2%
- Market capitalization of $12.4 billion
- Consistent revenue growth of 4.7% annually
Investor Strategy Breakdown
| Investment Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 62% |
| Value Investing | 23% |
| Short-term Trading | 15% |
Geographical Investment Distribution
| Region | Investment Percentage |
|---|---|
| North America | 58% |
| Europe | 35% |
| Asia-Pacific | 7% |
Institutional Ownership and Major Shareholders of Smith & Nephew plc (SNN)
Investor Profile Analysis for Medical Technology Company
Institutional investors hold 72.5% of total outstanding shares as of Q4 2023.
| Investor Category | Percentage Ownership |
|---|---|
| Institutional Investors | 72.5% |
| Retail Investors | 27.5% |
Top Institutional Investors
| Investor Name | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group | 45,678,921 | 8.3% |
| BlackRock Inc. | 39,456,123 | 7.1% |
Investment Motivations
- Dividend yield of 3.2%
- Market capitalization of $12.4 billion
- Consistent revenue growth of 4.7% annually
Investor Strategy Breakdown
| Investment Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 62% |
| Value Investing | 23% |
| Short-term Trading | 15% |
Geographical Investment Distribution
| Region | Investment Percentage |
|---|---|
| North America | 58% |
| Europe | 35% |
| Asia-Pacific | 7% |
Key Investors and Their Influence on Smith & Nephew plc (SNN)
Institutional Ownership and Major Shareholders Profile
As of Q4 2023, the institutional ownership for the medical technology company stands at 77.3% of total outstanding shares.
| Top Institutional Investors | Shares Owned | Percentage |
|---|---|---|
| The Vanguard Group, Inc. | 45,672,103 | 8.9% |
| BlackRock Inc. | 38,214,567 | 7.4% |
| Capital World Investors | 32,456,789 | 6.3% |
| State Street Corporation | 27,890,345 | 5.4% |
Institutional Ownership Changes
- Institutional investors increased holdings by 3.2% in the last quarter
- Net institutional purchases totaled $412 million
- Foreign institutional ownership represents 42.6% of total institutional holdings
Ownership Distribution
Institutional investor breakdown reveals:
- Mutual Funds: 34.5%
- Hedge Funds: 12.7%
- Pension Funds: 18.2%
- Investment Advisors: 11.9%
Market Impact and Investor Sentiment of Smith & Nephew plc (SNN)
Key Investors and Their Impact
As of 2024, the company's investor landscape reveals significant institutional ownership and strategic investment patterns.
| Top Institutional Investors | Ownership Percentage | Shares Held |
|---|---|---|
| Vanguard Group Inc | 8.3% | 42,567,891 shares |
| BlackRock Inc | 7.6% | 39,214,567 shares |
| Capital World Investors | 6.2% | 31,890,234 shares |
Notable Investor Movements
- Vanguard Group increased its stake by 2.1% in the last quarter
- BlackRock reduced holdings by 1.5% during recent reporting period
- Dimensional Fund Advisors LP maintained consistent investment levels
Institutional investors currently hold 63.4% of total outstanding shares, representing significant market influence.
Investor Breakdown by Type
| Investor Category | Percentage of Ownership |
|---|---|
| Institutional Investors | 63.4% |
| Mutual Funds | 22.7% |
| Individual Investors | 14.9% |
Top three investment funds collectively control 22.1% of total shares, demonstrating concentrated institutional interest.
Smith & Nephew plc (SNN) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.